STUDY_ACCESSION	ACTUAL_COMPLETION_DATE	ACTUAL_ENROLLMENT	ACTUAL_START_DATE	AGE_UNIT	BRIEF_DESCRIPTION	BRIEF_TITLE	CLINICAL_TRIAL	CONDITION_STUDIED	DCL_ID	DESCRIPTION	DOI	ENDPOINTS	GENDER_INCLUDED	HYPOTHESIS	INITIAL_DATA_RELEASE_DATE	INITIAL_DATA_RELEASE_VERSION	INTERVENTION_AGENT	LATEST_DATA_RELEASE_DATE	LATEST_DATA_RELEASE_VERSION	MAXIMUM_AGE	MINIMUM_AGE	OBJECTIVES	OFFICIAL_TITLE	SPONSORING_ORGANIZATION	TARGET_ENROLLMENT	TYPE	WORKSPACE_ID
SDY404		72	2011-01-01 00:00:00	Years	Project 1: Immunologic and genomic signatures of influenza vaccine response  - year2 2011	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	N	Immunologic and genomic signatures of influenza vaccine response	2	Project 1: Immunologic and genomic signatures of influenza vaccine response  - year2 2011	10.21430/M3GWQRC8DT	B cells (ASC, Memory); T cells (Ag specific CD8 and CD4, memory T cell subsets, Tregs, exhausted/senescent); in vitro activation of flu-specific T cells; Monocyte/DC stim by flu or through TLRs; innate cell TLR expression; Luminex assays of cytokines post vaccine; Illumina HT12 bead chip and Nanostring.	Both	Define signatures for immune responsiveness by functional systems immunology	2016-02-05 00:00:00	DR17	Trivalent inactivated influenza	2016-02-05 00:00:00	DR17	90	22	Identification of immunologic, gene expression, and genetic loci signatures of vaccine response, and effects of aging and functional status on these signatures.	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	NIAID		Observational	2668
